Conference Proceedings

Monday 15 November 2010

0900 – 1930	Registration & Information
1300 – 1400	Kickoff & Introduction Keynote Speaker – Dr. Alan Rudolph, Defense Threat Reduction Agency, Director of Chemical and Biological Technologies
1400 - 1530	Special Panel - Security Implications and Synthetic Biology: How Do We Pursue Science and Control Proliferation? Panel Chair - Dr. Robert Carlson
1530 – 1600	Break
1600 – 1730	Special Panel - Implementing Transformation in the Medical Countermeasure (MCM) Development Enterprise Panel Chair - Dr. Richard Jaffe
1730 – 1800	Break
1800 – 2000	Welcome/Poster Session Reception I

Tuesday 16 November 2010

0700 – 1830	Registration & Information
0700 – 0800	Continental Breakfast
0800 – 0900	Keynote Speaker – Dr. Robert Grubbs, Victor and Elizabeth Atkins Professor of Chemistry, California Institute of Technology
0900 – 0930	Break
0930 – 1200	Session 1: Pathogen Characterization, Identification and Evaluation: Linking Phenotype to Genotype Session 2: Preparing for Technology Transition: Advanced Development and Demonstration of CB Defense Technologies Session 3: Agent-Based Modeling and Disease Propagation Session 4: Assessing Dermal Exposure Hazards Session 5: Human Performance in a CBRN Environment
1200 – 1400	Lunch
1400 – 1730	Session 1: Chemical and Biological Agent/Substrate Interactions Session 2: Novel Sensing Science for Chemical and Biological Agents Session 3: Novel Materials Science for CB Defense Applications Session 4: Pathogen-Directed Therapeutics Session 5: Hazard Mitigation and Contamination Control
1730 – 1800	Break
1800 – 2000	Poster Session Reception II

Wednesday 17 November 2010

0700 – 1800	Registration & Information
0700 – 0800	Continental Breakfast
0800 – 0900	Keynote Speaker – Dr. David J. Galas, Professor and Senior Vice President, Institute for Systems Biology
0900 – 0930	Break
0930 – 1200	Session 1: Novel Materials for CB Protection Session 2: Chemical and Biological Agent Characterization Session 3: Biological Detection: Alternatives to Antibodies Session 4: CBRN Virtual Environments Session 5: Novel Vaccine Technologies
1200 – 1400	Lunch
1400 – 1600	Session 1: Novel Materials for CB Protection Session 2: Biologically Inspired Materials for CB Defense Session 3: Chemical Detection: Novel Sensors for Point Detection Session 4: CBRN Virtual Environments Session 5: Medical Radiological Countermeasure Development
1600 – 1630	Break
1630 – 1800	Special Panel – Countering WMD: Convergence of Science and Policy for Success in the 21st Century Panel Chair - Dr. Seth Carus

Thursday 18 November 2010

0700 – 1830	Registration & Information
0700 – 0800	Continental Breakfast
0800 – 0900	Keynote Speaker – The Honorable Dr. Tara O’Toole, Under Secretary for Science and Technology, Department of Homeland Security
0900 – 0930	Break
0930 – 1200	Session 1: Medical Chemical Countermeasure Development Session 2: Host-Pathogen Interactions Session 3: Standoff Detection: Detection of Surface Contamination Session 4: Fundamental Mechanisms of Molecular and Cellular Injury Following Exposure Chemical Warfare Agents Session 5: International CB Defense Research
1200 – 1400	Lunch
1400 – 1600	Session 1: Medical Chemical Countermeasure Development Session 2: Host-Pathogen Interactions Session 3: Host-Directed Therapeutics and Immunomodulation Session 4: Air Purification Session 5: Incorporating CB Effects into US Government Models/Applications
1600 – 1700	Special Poster Session
1700 – 1800	Break
1800 – 2000	Awards Dinner/Closing Ceremony Keynote Speaker – The Honorable Dr. Richard J. Danzig, Chairman of the Board, Center for a New American Security

Friday 19 November 2010-Industry Day

0700 – 1400	Registration & Information
0700 – 0800	Continental Breakfast
0800 – 0845	Acquisition Opportunities for Chemical/ Biological Research & Development at DTRA Mrs. Amanda Richardson, Defense Threat Reduction Agency Mr. Larry Pollack, Defense Threat Reduction Agency
0845 – 0915	Doing Business with DTRA Mr. Ken Harsha, Defense Threat Reduction Agency
0915 – 0930	Small Business and Supplier Diversity Mr. Ed Archer, Defense Threat Reduction Agency
0930 – 1030	What Is an Approved Accounting System – and Why I Should Care? Your Contract Award Depends on It! ... and ... You Need to Know This Before You Ever Submit a Proposal to the DoD Mr. Michael Hembree, Defense Contract Audit Agency (DCAA), Orlando Branch Office
1030 – 1045	Break
1045 – 1200	Joint Science & Technology Office for Chemical and Biological Defense (JSTO-CBD), Technology Capability Summary Presentations Basic & Supporting Research Division Medical Science & Technology Division Transformational Medical Technologies Program Physical Science & Technology Division Information Systems Capability Development Division
1200 – 1300	Lunch
1300 – 1430	The Threat of Biological Warfare: Lessons from the Past and Strategies for the Future - Mr. David E. Hoffman, Contributing Editor at The Washington Post and Foreign Policy magazine and Dr. Jason Rao, Senior Policy Advisor for Global Science Engagement, White House Office of Science and Technology Policy
1430 – 1600	Divisional Interactions Session: Basic & Supporting Research Division Session: Medical Science & Technology Division Session: Transformational Medical Technologies Program Session: Physical Science & Technology Division Session: Information Systems Capability Development Division